A Glimpse Into The Expert Outlook On Staar Surgical Through 4 Analysts
Portfolio Pulse from Benzinga Insights
Over the past three months, four analysts have evaluated Staar Surgical (NASDAQ:STAA), offering a range of opinions from bullish to bearish. The average 12-month price target is now $44.25, down from $46.33. Recent analyst actions include Canaccord Genuity lowering its price target to $41.00, BTIG raising it to $53.00, and Morgan Stanley lowering it to $37.00.
August 08, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Staar Surgical (NASDAQ:STAA) has received mixed analyst ratings over the past three months, with recent price targets ranging from $37 to $53. The average 12-month price target has decreased to $44.25 from $46.33.
The mixed analyst ratings and the decrease in the average price target suggest uncertainty about Staar Surgical's short-term performance. While some analysts are bullish, others are bearish, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100